- Home
- DSY vs NVCT Comparison
DSY vs NVCT Comparison
Compare DSY & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- NVCT
- Stock Information
- Founded
- DSY 2020
- NVCT 2020
- Country
- DSY China
- NVCT United States
- Employees
- DSY N/A
- NVCT 13
- Industry
- DSY
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- DSY
- NVCT Health Care
- Exchange
- DSY Nasdaq
- NVCT Nasdaq
- Market Cap
- DSY 130.7M
- NVCT 110.3M
- IPO Year
- DSY N/A
- NVCT 2022
- Fundamental
- Price
- DSY $2.60
- NVCT $5.75
- Analyst Decision
- DSY
- NVCT Strong Buy
- Analyst Count
- DSY 0
- NVCT 1
- Target Price
- DSY N/A
- NVCT $21.00
- AVG Volume (30 Days)
- DSY 51.6K
- NVCT 104.2K
- Earning Date
- DSY 02-10-2025
- NVCT 03-04-2025
- Dividend Yield
- DSY N/A
- NVCT N/A
- EPS Growth
- DSY 120.37
- NVCT N/A
- EPS
- DSY 0.01
- NVCT N/A
- Revenue
- DSY $7,323,356.00
- NVCT N/A
- Revenue This Year
- DSY N/A
- NVCT N/A
- Revenue Next Year
- DSY N/A
- NVCT N/A
- P/E Ratio
- DSY $279.76
- NVCT N/A
- Revenue Growth
- DSY 16.37
- NVCT N/A
- 52 Week Low
- DSY $0.75
- NVCT $4.44
- 52 Week High
- DSY $13.47
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- DSY 43.40
- NVCT 52.35
- Support Level
- DSY $2.65
- NVCT $5.34
- Resistance Level
- DSY $3.64
- NVCT $5.95
- Average True Range (ATR)
- DSY 0.43
- NVCT 0.48
- MACD
- DSY -0.04
- NVCT 0.02
- Stochastic Oscillator
- DSY 14.80
- NVCT 32.19
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.